eLearning

Posted By Matt Baughman
Found In Microsite: AAPS Newsmagazine
Table of Contents AAPS eLearning March 2021 By Cathy Yarbrough Over the past decade, China has overhauled its regulations governing drug development and approval. In addition to encouraging medical innovation, China’s regulatory reforms are designed ...
Posted By Matt Baughman
Found In Microsite: AAPS Newsmagazine
Drug researchers are turning to computational chemistry to more quickly learn about potential drug targets as they develop treatments for COVID-19 and other pandemics By David Pittman It can take up to a decade for a drug to move from the discovery ...
Posted By Matt Baughman
Found In Microsite: AAPS Newsmagazine
by Cathy Yarbrough Global drug pipelines contain an “increasing number of low solubility and poor permeability compounds,” David Lyon, Ph.D., Research at Lonza, said when introducing the AAPS webinar, Advances in bioavailability enhancing technologies ...
Posted By Matt Baughman
Found In Microsite: AAPS Newsmagazine
A recent webinar highlights challenges to this new treatment.  By Mark Crawford Dhananjay Jere, senior principal scientist with Lonza Drug Product Services, and Zhimei Du, director and chemistry, manufacturing, and controls (CMC) lead for Merck, ...
Posted By Matt Baughman
Found In Microsite: AAPS Newsmagazine
The agency tasked with regulating drug approvals can provide researchers with the best source of data on other new products.  By David Pittman   The Food and Drug Administration (FDA)—while also the gatekeeper of what drugs do and don’t make it into ...